Shares of Pharnext SA (OTCMKTS:PNEXF – Get Free Report) traded up 399,999,900% during mid-day trading on Monday . The company traded as high as $400.00 and last traded at $400.00. 16,660 shares traded hands during trading, an increase of 3,748% from the average session volume of 433 shares. The stock had previously closed at $0.00.
Pharnext Price Performance
The business’s 50 day moving average is $400.00 and its 200 day moving average is $400.00.
Pharnext Company Profile
Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for neurodegenerative diseases with high unmet medical needs. Its products include PXT3003, a novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol formulated that is in Phase III clinical trials for the treatment of Charcot-Marie-tooth disease type 1A; and PXT864 to treat amyotrophic lateral sclerosis.
See Also
- Five stocks we like better than Pharnext
- What Do S&P 500 Stocks Tell Investors About the Market?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What Are the U.K. Market Holidays? How to Invest and Trade
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Pharnext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharnext and related companies with MarketBeat.com's FREE daily email newsletter.
